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Ubiquitin (Ub) and ubiquitin-like proteins (Ubls) are
conjugated to their targets by specific cascades
involving three classes of enzymes, E1, E2, and E3.
Each E1 adenylates the C terminus of its cognate
Ubl, forms a E1Ubl thioester intermediate, and ulti-
mately generates a thioester-linked E2Ubl product.
We have determined the crystal structure of yeast
Uba1, revealing a modular architecture with individ-
ual domains primarily mediating these specific activ-
ities. The negatively charged C-terminal ubiquitin-
fold domain (UFD) is primed for binding of E2s and
recognizes their positively charged first a helix via
electrostatic interactions. In addition, a mobile loop
from the domain harboring the E1 catalytic cysteine
contributes to E2 binding. Significant, experimentally
observed motions in the UFD around a hinge in the
linker connecting this domain to the rest of the
enzyme suggest a conformation-dependent mecha-
nism for the transthioesterification function of Uba1;
however, this mechanism clearly differs from that of
other E1 enzymes.
INTRODUCTION
The covalent attachment of the small, highly conserved protein
ubiquitin (Ub) to target proteins is an essential mechanism for
modulating the function of these proteins in eukaryotes, and its
defective regulation has been shown to cause pathological con-
ditions that range from developmental abnormalities and cancer
to autoimmune and neurodegenerative diseases (Hershko and
Ciechanover, 1998). Ub is covalently conjugated via its C termi-
nus to its cellular target proteins by a conserved biochemical
pathway that involves the sequential actions of Ub-activating
(E1), Ub-conjugating (E2), and Ub-protein ligase (E3) enzymes
(Hershko and Ciechanover, 1998).
The E1 activity represents an essential step during Ub and
ubiquitin-like protein (Ubl) conjugation, and the general mecha-
nism of the E1-catalyzed reaction is well established, on the268 Cell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc.basis of early work with the Ub-E1 (Haas and Rose, 1982;
Haas et al., 1982; Hershko et al., 1983). Each Ubl has a dedicated
E1 that initiates its conjugation cascade. First, E1 associates
with the Ubl and catalyzes the adenylation of the Ubl C terminus
in an ATP-dependent process. Second, E1 forms a thioester
between a conserved catalytic cysteine and the Ubl. Next, E1
is loaded with a second Ubl molecule, followed by its C-terminal
adenylation. Finally, the ternary E1Ubl thioester complex
recruits an E2 to facilitate transfer of the thioester-linked Ubl to
a conserved E2 cysteine (transthioesterification). The energy
stored in the E2Ubl thioester is utilized to conjugate Ubl to tar-
get lysine 3-amino groups, either directly or through complexes
mediated by E3s.
The E1 for Ub is a 110–120 kDa monomeric protein, whereas
the E1s for the Ubls NEDD8 and SUMO are heterodimeric com-
plexes with comparable overall molecular weights. All eukaryotic
E1s contain a two-fold repeat of a domain that is derived from the
bacterial MoeB and ThiF proteins (Johnson et al., 1997), with one
occurrence each in the N-terminal and C-terminal half of the E1
for Ub, or the separate subunits of the E1 for NEDD8 and SUMO.
MoeB and ThiF catalyze the C-terminal adenylation of MoaD and
ThiS, respectively, which are structural homologs of Ubl in the
context of either molybdenum cofactor or thiamin biosynthesis
(Duda et al., 2005; Lake et al., 2001; Lehmann et al., 2006).
The Ub-E1 consists of four building blocks: First, the adenyla-
tion domains composed of two MoeB/ThiF-homology motifs
(hereafter, IAD and AAD, for ‘‘inactive’’ and ‘‘active’’ adenylation
domain, respectively), the latter of which binds ATP and Ub (Lake
et al., 2001; Lois and Lima, 2005; Walden et al., 2003b); second,
the catalytic cysteine half-domains, which contain the E1 active
site cysteine (hereafter, FCCH and SCCH, for ‘‘first’’ and ‘‘sec-
ond’’ catalytic cysteine half-domain, respectively) inserted into
each of the adenylation domains (Szczepanowski et al., 2005);
third, a four-helix bundle that represents a second insertion in
the IAD and immediately follows the FCCH; and fourth, the C-ter-
minal ubiquitin-fold domain (UFD), which recruits specific E2s
(Huang et al., 2005, 2007; Lois and Lima, 2005). Despite the cen-
tral role of the E1 enzyme in the Ub conjugation cascade, a struc-
ture of an intact Ub-activating enzyme has not been available so
far. Here, we present the crystal structure of the Saccharomyces
cerevisiae Ub-activating enzyme, known as Uba1, bound to
yeast Ub, and on the basis of structural and biochemical data
advance our understanding of the function and mechanism of
the Ub-specific E1.
RESULTS AND DISCUSSION
Overall Structure of the Uba1-Ub Complex
The S. cerevisiae Uba1-Ub complex was crystallized, and its
structure was determined by domain-wise molecular replace-
ment with several search models (see the Supplemental Exper-
imental Procedures available online). The structure was refined
to an R/Rfree of 0.194/0.247 at 2.7 A˚ resolution (Table 1). Although
the crystals only diffracted to 2.7 A˚, virtually all residues are
clearly defined (Figure S1), and there is no significant disorder
in the protein itself. There are two molecules of the 120 kDa
Uba1-Ub complex in the asymmetric unit, and they exhibit
almost identical conformations except for the C-terminal UFD.
Table 1. Data Collection and Refinement Statistics
Data Collection Statistics
Space group P212121
Unit cell dimensions (A˚) a = 115.36, b = 118.56,
c = 207.57
Complexes per asymmetric unit 2
X-ray source NSLS, beamline X29
Wavelength (A˚) 1.1
Resolution limits (A˚) 502.7
Number of observations 503,923
Number of unique observations 77,706
Completeness (%) 98.5 (86.9)
Rmerge
a (%) 11.5 (41.2)
<I/sI > 15.9 (1.7)
Mean redundancy 6.5
Refinement Statistics
Resolution (A˚) 202.7
Number of protein/solvent atoms 17,051/176
Ra (Rfree) (%) 19.4 (24.7)
Rms bond length deviations (A˚) 0.012
Rms bond angle deviations () 1.366
Rms chiral volume deviations (A˚3) 0.099
Rms planar group deviations (A˚) 0.004
Overall average B -factors
(protein/solvent atoms, A˚2)
38.4/33.8
Ramachandran statisticsa (%) 95.0/4.2/0.8
a Rmerge =
P
hkl
P
kjI(k)  [I]j/
P
hkl
P
kI(k), where I(k) is the value of the k
th
measurement of the intensity of a reflection, [I] is the mean value of the
intensity of that reflection, and the summation is over all the measure-
ments. Brackets denote the highest-resolution shell (2.82.7 A˚). R =
P
hkljFobs Fcalj/
P
hkljFobsj, where Fobs and Fcal are the observed and cal-
culated structure factors, respectively, for all data (no s cutoff). Rfree = R
calculated with 5% of the reflection data chosen randomly and omitted
prior to the start of refinement. Ramachandran statistics have been deter-
mined with MolProbity (Davis et al., 2004) and refer to the percentage of
residues in the core/allowed/disallowed regions of the Ramachandran
diagram.Without the UFD, the two Uba1 molecules can be superimposed
with a root-mean-square deviation (rmsd) of 1.08 A˚ over 933 (out
of a total of 1024) aligned Ca atoms. The UFDs can be separately
superimposed, resulting in a rmsd of 0.60 A˚ over 96 aligned Ca
atoms, indicating a rigid body displacement of the UFD between
the two complexes, whereas the Ub molecules (residues 1–76)
can be superimposed with a rmsd of 0.35 A˚.
The Uba1 structure consists of a complex arrangement of six
structural domains referred to as IAD, AAD, FCCH, SCCH, 4HB,
and UFD as introduced earlier with overall dimensions of 85 A˚3
90 A˚ 3 60 A˚ (Figure 1). In the structure, four domains, AAD,
FCCH, SCCH, and UFD, pack together to generate a large cen-
tral canyon (40 A˚ wide), which at one end (near FCCH) snugly
recruits a Ub molecule. The large size of the canyon in Uba1 sug-
gests that it may function to accommodate an E2, as well.
The UFD, FCCH, and SCCH domains are connected to their
respective adjacent domains by three flexible linkers: (1) UFD
is attached to AAD by an 18 residue loop forming a b-hairpin at
the end of the AAD. This stretch will be referred to as the UFD
linker. (2) FCCH is connected to IAD by two long antiparallel
b strands. (3) Finally, SCCH is linked to AAD by an extended
18 residue linker that traverses 40 A˚ from one side of the mole-
cule to the other. This crossover loop divides the canyon into
two clefts that are continuous both below and above the loop.
As in the previous E1 structures (Lois and Lima, 2005; Walden
et al., 2003a), when viewed facing the E1 catalytic cysteine
located centrally above AAD, Ub’s globular domain binds in
the right cleft (cleft 2) with its C-terminal tail extending under
the crossover loop (Figure 1) to approach the adenylation active
site in the left cleft (cleft 1). The structural features described
above suggest that Uba1 may undergo large-scale conforma-
tional changes during the course of its functional cycle, an idea
that is supported by other structural details and biochemical
studies that will be described later.
E1 enzymes from various organisms including yeast Uba1
share extensive sequence homology (Figure S2); for example,
Uba1 and its human ortholog (Ube1) display an overall sequence
identity of 50%, with all structural domains being highly con-
served. Furthermore, yeast and human Ub share 96% sequence
identity. Taken together, these data indicate that Ube1 will adopt
the same architecture as Uba1 and activate as well as transfer
Ub in a similar fashion.
Molecular Features Underlying Recognition
of Ubiquitin by E1
Besides their essential role in initiating Ubl conjugation cas-
cades, E1s select the correct Ubl for their respective pathways.
Each Ubl has a dedicated E1, which displays remarkable spec-
ificity. For example, despite the fact that Ub and NEDD8 share
57% sequence identity and have markedly similar structures,
they are distinguished by their respective E1s (Whitby et al.,
1998). This specificity is crucial because the E1 also transfers
the activated Ubl to its cognate E2, thereby coupling the Ubl to
its correct downstream pathway. The structure of the Uba1-Ub
complex suggests the basis for part of the preference of E1s
for their particular Ubls. Residue 72 is the only known determi-
nant of selectivity in Ubls for their E1s (Bohnsack and Haas,
2003; Walden et al., 2003a; Whitby et al., 1998), which is anCell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc. 269
Figure 1. Overall Structure of the Uba1-Ub Complex
(A) Cartoon diagram of the Uba1-Ub complex with a helices as cylinders and b strands as curved arrows. The six domains of Uba1 are colored as follows: ad-
enylation (A) domains in cyan (IAD) and purple (AAD), the two subdomains of the catalytic cysteine (CC) domain in green (FCCH) and blue (SCCH), the ubiquitin-
fold domain (UFD) in red, and the four helix bundle (4HB) domain in pale cyan. Ub is displayed in yellow and the catalytic cysteine of Uba1 in pink. The overall size
of the complex is85 A˚ by90 A˚ by60 A˚, and there is an40 A˚ gap between the UFD and SCCH domains. N and C termini of Uba1 and Ub, as well as residues
785 and 794, which are adjacent to the disordered loop in the SCCH domain of Uba1, are labeled when visible.
(B and C) Alternate views of the complex that differ by 90 rotations around the vertical (B) and horizontal (C) axes as indicated.
(D) Domain architectures of Uba1, APPBP1/UBA3 (NEDD8-E1), Sae1/Sae2 (SUMO-E1), and the MoeB dimer colored according to the Uba1 structure.arginine in Ub, whereas an alanine in NEDD8 and either a gluta-
mate or a glutamine in SUMO family members are found at the
corresponding positions.
The Uba1-Ub interactions result in the burial of 3200 A˚2 of
exposed surface area, corresponding to 33% of Ub’s total sur-
face area. A similar value was observed in the case of the
NEDD8-E1, which buries 3350 A˚2 of total surface area with
NEDD8 (34% of NEDD8) (Walden et al., 2003a). In contrast, the
SUMO-E1-SUMO interface buries only 1650 A˚2 (20% of
SUMO) (Lois and Lima, 2005). Most of the interactions involving
Ub binding are localized to the four-stranded b sheet (b21–b24)
preceding the UFD and the crossover loop (Figure 2). The details
of the interface between Uba1 and Ub are described by dividing
it into three areas: (1) the hydrophobic interface between the
‘‘canonical’’ hydrophobic patch of Ub and the conserved AAD
of Uba1 (Interface I), (2) the interactions between Ub’s C-terminal
tail and the AAD as well as the crossover loop (Interface II), and
(3) the polar interface between Ub and the FCCH (Interface III).270 Cell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc.The three interfaces are shown in Figures 2A, 2B, and 2C,
respectively.
Interface I is defined by extensive hydrophobic contacts be-
tween a hydrophobic patch on the surface of the AAD (b23 and
b24), involving Phe898, Leu903, and Phe905, and a hydrophobic
patch that is absolutely conserved between Ub and NEDD8 cen-
tered around Leu8, Ile44, and Val70 (Figure 2A), which are all
essential for viability in yeast (Sloper-Mould et al., 2001). In addi-
tion to these hydrophobic contacts, this interaction is stabilized
by a hydrogen bond between Uba1’s Asn900 and the carbonyl
oxygen of Ub’s Leu8. Phe283 and Ala284, which are located in
the turn between the first and the second a helix (a6 and a7) of
the 4HB, interact with Ala46 and Gly47 present in the turn be-
tween the third and fourth b strand (b3 and b4) of Ub and support
it from underneath.
Interface II involves Ub’s C-terminal tail, which extends away
from the hydrophobic patch and sits in a shallow groove in the
AAD, below the crossover loop, where it adopts a highly similar
conformation to that of NEDD8 and SUMO in complex with their
cognate E1s, as well as the bacterial MoaD in complex with its
activator MoeB. The Arg72 side chain of Ub binds into a nega-
tively charged pocket created by residues from the crossover
Figure 2. Detailed Views of the Three Uba1-Ub Interfaces
(A) Interface I involves the hydrophobic surface on Ub (yellow) and the AAD
(magenta) and Phe283/Ala284 in the 4HB (pale cyan). Domains are colored
as in Figure 1, including the corresponding carbon atoms, whereas nitrogen
atoms are shown in blue and oxygen atoms in red. Critical residues in the in-
terface are shown in all-bonds representation. Dashed lines indicate hydrogen
bonds.
(B) Interactions between Ub’s C-terminal tail (yellow) with the AAD and cross-
over loop (magenta) define interface II. The side chain of Arg590 of Uba1 has
been omitted for clarity.
(C) Interface III is located between Ub (yellow) and the FCCH (green).loop (Figure 2B). The Arg72 guanidinium group forms a network
of charge-stabilized hydrogen bonds with the side chains of
Gln576 and Asp591 and with the backbone carbonyl groups of
Tyr586 and Ser589, in a partially buried environment. In contrast,
in the NEDD8-E1 complex, UBA3’s hydrophobic Leu206 and
Tyr207 interact with Ala72 of NEDD8 (Walden et al., 2003a),
and in SUMO-E1, Sae2’s Arg119 and Tyr159 contact Glu93 of
SUMO-1 (Lois and Lima, 2005), indicating together that each
Ubl makes distinct and favorable interactions with the crossover
loop of its E1. In this region, the guanidinium group of Ub’s Arg42
also forms a hydrogen bond network with the hydroxyl group of
Ser589, the backbone carbonyl group of Arg590, and the side
chain of Asp591, providing a rationale for the observation that
mutation of Ub’s Arg42 to leucine reduces E1’s affinity for the
Ubadenylate by three orders of magnitude (Burch and Haas,
1994). An additional salt bridge is found between Uba1’s
Glu594 and Ub’s Arg74, which has also been shown to play a crit-
ical role in Ub activation; mutation of Arg74 to leucine reduces
the rate of ATP:PPi exchange (Burch and Haas, 1994). Alignment
of seven Uba1 orthologs shows that the surface that interacts
with Ub’s C-terminal tail is strictly conserved and that the
residues contacting Arg42, Arg72, and Arg74 are invariant
(Figure S2). A superposition with the ATP-bound structure of
the MoaD-MoeB complex and the MoaD-adenylate (Lake
et al., 2001) reveals that the catalytically important residues
Asp544, Arg481 (from AAD), and Arg21 (from IAD) in the adeny-
lation active site adopt similar conformations with their counter-
parts.
Finally, one face of Ub’s globular domain interacts with the
FCCH (Figure 2C). In this region (Interface III), Ub contacts the
subdomain comprised of Uba1’s residues 175–265 that forms
one wall of the broad, deep groove in the Uba1 structure. This
portion of the interface is unique to eukaryotic E1s and is not
found in distant bacterial ancestors such as MoeB and ThiF.
The nature of this interface is predominantly polar, with four
residues (Lys11, Thr12, Gln31, and Asp32) of Ub forming hydro-
gen bonds with three Uba1 residues (Arg202, Gly204, and
Glu206), and the interface buries 560 A˚2 of surface area. In
case of NEDD8-E1, this polar interface is more extensive,
involving the whole acidic face of helix a1 and the subsequent
loop in NEDD8 (Walden et al., 2003a), whereas this interface
appears to be absent in the SUMO-E1 complex (Lois and
Lima, 2005).
Structural Insights into Formation of the E1Ubl
Thioester Intermediate
The SCCH contains the E1 catalytic cysteine that forms a thio-
ester with the C terminus of Ub and promotes transfer of Ub
to its E2. Formation of the thioester complex between Uba1
and Ub proceeds through a nucleophilic attack on the
Ubadenylate by the E1 active site cysteine. This reaction pre-
sumably involves deprotonation of E1’s active site cysteine by
a general base catalyst. The basic residue that is closest (less
than 5 A˚) to the active site cysteine in yeast Uba1 is Arg603,
which is conserved as a lysine among Ub-E1s from different
species. However, Arg603 is unlikely to act as a general base,
both chemically and structurally. Asp782 is conserved as a neg-
atively charged residue in all Ub-E1s (Figure S2), and itsCell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc. 271
potential role as a general base was analyzed. Mutation of
Asp782 to alanine or asparagine has little effect on the Uba1-
Ub thioester formation, rendering such a model improbable
(data not shown). However, the apparent lack of a convincing
general base residue near the active site cysteine does not pre-
clude a possible realignment of additional residues through
a conformational change during the reaction, or substrate-assis-
ted catalysis via an E2-derived residue.
Another requirement for E1Ub thioester formation is that the
active site cysteine needs to be in close proximity to the Ub C ter-
minus. In the crystal structure, the thiol of Cys600 is 35 A˚ away
from the adenylation active site, similar to the structures of both
the NEDD8-E1 and SUMO-E1, thus strongly suggesting that sig-
nificant conformational changes in the complex would be re-
quired for the juxtaposition of the bound Ubadenylate and
the active site cysteine thiol. The gap can be reduced by the
movement of Ub’s flexible C-terminal tail, a change in the relative
orientations of the AAD, SCCH, and FCCH domains via hinge
motions in the extended loops linking the domains, and a poten-
tial local conformational change around the catalytic cysteine in
the SCCH as proposed by Walden et al. (2003a). Additionally, the
catalytic cysteine must retract with the nascent Ub thioester after
the formation of the thioester linkage to allow the adenylation of
a second Ub molecule. However, the nature of these hypotheti-
cal conformational changes is still unclear.
E2 Recognition: Specificity Element
in the E1 UFD-E2 Interface
The ultimate function of E1 is to coordinate the transfer of its
activated Ubl to the cognate E2 enzyme. This involves E1 inter-
acting noncovalently with one of the cognate E2 enzymes and
a subsequent transthioesterification reaction in which the Ubl is
transferred from E1’s catalytic cysteine to that of the E2. In the
Ub pathway, a single E1 enzyme (in yeast) sits at the top of the
cascade, transferring Ub to many different E2s, one at a time.
The fully loaded E1 has a high affinity for E2s, with dissociation
constants (Kd) in the subnanomolar to nanomolar range depend-
ing on the E2 (Haas et al., 1988). However, the Ub-E1 only dis-
plays a low affinity for E2s in the absence of Ub and ATP, because
E1 readily separates from the E2s during purification without ATP
(Hershko et al., 1983). The low affinity of the free E1 for E2s might
expedite the rapid cycling of E1, so that it can charge Ub’s vari-
ous E2s (Hershko et al., 1983; Huang et al., 2004b). In contrast,
the Ubls NEDD8 and SUMO have only one known E2 in each of
their cascades. Although the Km is not a measure of complex
stability, it should be pointed out that the Km for NEDD8’s E2,
Ubc12, during the ternary complex formation is similar to
those for Ub-E2s (Bohnsack and Haas, 2003). However, both
Ubc12 and the E2 for SUMO family members, Ubc9, have been
shown to bind their E1s in the free state (Bencsath et al., 2002;
Walden et al., 2003b; Wang et al., 2007) in contrast to the E2s
for Ub.
The recent crystal structure of a complex between the C-ter-
minal domain (UFD) from NEDD8’s heterodimeric E1 (APPBP1-
UBA3) and the catalytic core domain of Ubc12 (Huang et al.,
2005) revealed that the N-terminal helix (H1) and the loop be-
tween the first and second b strand (b1b2 loop) of the E2 bind
to the concave surface formed by UFD’s twisted b sheet, in272 Cell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc.a manner that resembles Ub’s interactions with ubiquitin-binding
domains (UBDs). The location of the E1 binding site is probably
conserved among E2s for Ub and other Ubls because two stud-
ies of E2s for Ub revealed that mutations in H1 diminished
E2Ub thioester bond formation (Pitluk et al., 1995; Sullivan
and Vierstra, 1991). In addition, in another Ub-E2, Ubc13, a pro-
tein-protein interaction that blocks access to this surface, im-
pairs E2Ub thioester bond formation (McKenna et al., 2001;
Moraes et al., 2001; VanDemark et al., 2001).
Although it is difficult to directly discern the structural basis for
specificity from the interface between E2 and UFD, it is possible
to identify differences between either UFD or E2 sequences
within the postulated interface that may contribute to specificity.
Notably, the E2-binding grooves of Uba1’s UFD (Figure 3A), and
to some extent Sae2’s UFD (data not shown), have distinct
charge distributions. Both feature a generally acidic surface;
however, Uba1’s UFD is more acidic, with three conserved
acidic residues (Glu1004, Asp1014, and Glu1016) clustered in
the last two C-terminal b strands (b30 and b31). When the com-
plex between the UFD of Uba1 and Ubc1 is modeled (see the Ex-
perimental Procedures), these three residues appear to make
contacts with Lys5 and Lys9 from helix H1 of Ubc1 (S. cerevisiae
numbering). The alignment of yeast E2 sequences reveals that
these two lysines are conserved in most E2 sequences, except
in Ubc3, Ubc9, and Ubc12 (Figure 3B). Notably in Ubc9, which
is the only SUMO-conjugating enzyme, the second lysine is
replaced by a glutamate, whereas a hydrophobic residue (Ile)
is present at the position of the first lysine in Ubc12, the
NEDD8-E2. The crystal structure of the NEDD8-E1 in complex
with its E2 (Huang et al., 2007) reveals that electrostatic interac-
tions between the N-terminal helix of Ubc12 and the UFD do not
play a prominent role in stabilizing the complex.
To investigate the contribution of negatively charged residues
in the UFD of Uba1 and positively charged residues in E2 en-
zymes, exemplified by Ubc1, we analyzed mutations of the con-
served acidic residues Glu1004, Asp1014, and Glu1016 from the
E2-binding surface of UFD, as well as the positively charged res-
idues Lys5 and Lys9, in single-turnover pulse-chase Uba1-Ubc1
transthioesterification assays (Huang et al., 2007; Petroski and
Deshaies, 2005). These studies were used in order to specifically
examine effects of mutations in either Uba1 or Ubc1 on Ub trans-
fer from Uba1 to Ubc1, without detecting effects of mutations on
any other functions of Uba1, such as binding, adenylation, and
covalent attachment of Ub. A single charge reversal mutation
in the UFD (E1004K) already drastically reduces the formation
of the Ubc1Ub thioester product, with the D1014K/E1016K
double mutant and the corresponding triple mutant showing an
even more pronounced reduction (Figure 3C and Figure S3). At
the same time, single charge reversals of either Lys5 or Lys9 sig-
nificantly reduce activity (in particular K5E), whereas the corre-
sponding double mutant renders the protein nearly inactive in
this assay. In addition to the electrostatic interactions, the
b1b2 loop of Ub-E2s likely interacts with residues from b29 of
Uba1’s UFD; however, the prominent structural differences in
this region between Ub-E2s make it difficult to assess these
potential interactions. For further characterization of the E1-E2
interface, the structural analysis of at least one Ub E1-E2 com-
plex will be required.
Figure 3. Interactions between the UFD of Uba1 and its Cognate E2
Enzymes
(A) Electrostatic surface representation of Uba1’s negatively charged UFD
(contoured at ±12 kBT) reveals an electrostatic complementarity with positively
charged residues in helix 1 (H1) of Ubc1. Helix H1 of Ubc1 was modeled as
described in the Experimental Procedures, and the conformations of the
Lys5, Lys9, and Gln12 side chains were adjusted to avoid steric clashes.
The black arrows point to the side chains from UFD that presumably contact
the residues mentioned above.
(B) Multiple sequence alignment of several yeast Ub-specific E2 enzymes and
the E2s for SUMO (Ubc9) and NEDD8 (Ubc12). The numbering is based on
S. cerevisiae Ubc1. Magenta and cyan highlight residues that are conserved
among the Ub-E2s but not in Ubc9 and Ubc12. The alignment only includes
residues in a helix H1 (indicated on top) and adjacent residues.
(C) Mutational analysis of the transthioesterification reaction analyzed in sin-
gle-turnover pulse-chase Uba1-Ubc1 transthioesterification assays. The ex-
periment is schematically illustrated above the actual data. A time course
(0.5, 2, and 6 min) for the formation of the Ubc1Ub product is shown after
the initial generation of the Uba1Ub complex in the ‘‘pulse’’ reaction (see
the Experimental Procedures). After the initial thioester formation wasConformational Changes Associated
with Uba1-Catalyzed Transthioesterification
Upon docking of the structure of a complex between the UFD of
the E1 and E2 onto full-length structures of apo or singly Ubl-
loaded E1s for NEDD8 and SUMO (Huang et al., 2005; Lois
and Lima, 2005; Walden et al., 2003a), it became apparent that
the E2 would bind to the opposite side of and face away from
E1’s catalytic cysteine (summarized in Figure 4A and Figures
S4A–S4C). Thus, significant conformational changes were pre-
dicted to be required to enable the E1 and E2 catalytic cysteine
to face and approach each other in both of these E1 enzymes.
Indeed, the structure of the trapped (NEDD8)2-E1-E2 complex
(Huang et al., 2007) demonstrates that the UFD dramatically
changes its conformation to allow transthioesterification. During
this process, the Ubc12 binding site on the AAD, which interacts
with the UFD prior to E2 binding and hence is buried, becomes
unmasked.
In contrast, a detailed structural analysis of Uba1 suggests
that the Ub-E1 will likely undergo a distinct conformational
change, largely because of a difference in the architecture of
the protein. First, the ‘‘canyon’’ in Uba1 is much wider (40 A˚)
than that of other E1s (Figure 4A), and the UFD in the singly
Ub-loaded E1 structure presented here is in a comparable posi-
tion to the UFD of the doubly NEDD8-loaded E1. Furthermore,
based on where the thioester-linked Ub would bind according
to the orientation of the thioester-linked NEDD8 in the doubly
loaded complex, it would not clash with the UFD, as seen in
the case of NEDD8-E1, because of the presence of the much
larger gap in the E1 for Ub. Second, the E2-binding groove on
the Uba1 UFD faces toward the SCCH (Figure 4A), and as a con-
sequence, the E2 catalytic cysteine also faces in the direction of
E1’s large central groove, which contains both the Ub-binding
site and E1’s active site cysteine (Figure S4D). Third, in contrast
to what is seen in other E1s, a relatively small change in the UFD
linker can bring the E2 active site cysteine close to the E1 cyste-
ine. As mentioned earlier, the two complexes present in the
asymmetric unit differ in the orientation of their UFDs with re-
spect to the remainder of the protein (Figure 4B), and this confor-
mational change appears to be directly relevant for the trans-
thioesterification reaction. If one models the E2 interaction with
both UFD conformations, the width of the gap between the E1
and E2 catalytic cysteines decreases from 38 A˚ to 27 A˚. Fi-
nally, there are notable differences in the size and directionality
of the b-hairpin near the end of the UFD linker. In contrast to
the SUMO-E1 and NEDD8-E1, Uba1 contains an additional anti-
parallel b-hairpin (residues 915–927) that is facing ‘‘outward’’
(Figures S4A–S4C). Uba1 and all Ub-E1s are bereft of the zinc-
binding motif, which coordinates a zinc ion in the vicinity of the
hinge region. One implication of the absence of the zinc ion is
quenched with EDTA, the ‘‘chase’’ reaction was initiated by the addition of
Ubc1. The reaction mixture was stopped and withdrawn at the indicated times
and resolved by SDS-PAGE. Uba1Ub complex generated during the pulse
reaction and Ubc1Ub product generated during the chase reaction were vi-
sualized on the same gel with the Odyssey infrared imaging system. Wild-type
and charge reversal mutants of Uba1 are shown in the top row, whereas Ubc1
mutants are shown in the bottom row. The amount of Uba1 and Ubc1 used in
these experiments is shown on the right.Cell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc. 273
Figure 4. Comparison of E1 Structures and Conformational Changes in Uba1
(A) Ribbon and surface representations of the Uba1-Ub complex (left) and the APPBP1-UBA3-NEDD8 (PDB entry 1R4M [Walden et al., 2003a]) complex (right).
The catalytic cysteine is shown in pink. In the Uba1-Ub complex, the ‘‘canyon’’ between the SCCH and the UFD is considerably wider compared to the other
complex. Arrows highlight the respective binding sites for the N-terminal helix of each E2.
(B) Conformational changes in UFD and the UFD linker observed in the Uba1-Ub crystal structure. The two copies of the Uba1-Ub complex present in the asym-
metric unit were superimposed, with one complex colored in blue and the other in purple. The straight black arrow points to the UFD linker to highlight the con-
formational differences, whereas the curved arrow indicates the rotation of the UFD around the linker. Cys600 is highlighted as a sphere, and N and C termini of
Uba1 and residues adjacent to the disordered loop in the SCCH domain are labeled.that it causes the UFD linker in Uba1 to be more stretched out,
which contributes to the wide gap between the SCCH and the
UFD. Because of these structural differences, it is likely that
the Ub-E1 does not require the dramatic conformational change
in the UFD linker hinge observed for the NEDD8-E1 and probably
also the SUMO-E1, and hence a smaller conformational change
in the orientation of the UFD is sufficient to allow the transthioes-
terification to proceed.
On the basis of the singly Ub-loaded Uba1 crystal structure,
a structural model of a transthioesterification complex for the
Ub-E1 has been generated (Figures 5A and 5B). The model
shows that, in contrast to the 120 rotation for the UBA3 UFD
of the NEDD8-E1, a significantly smaller rotation of the UFD by
only 40 around the hinge region formed by residues 912–
914 (Figure 5C) would bring Uba1’s and Ubc1’s catalytic cyste-
ines into close spatial proximity, as reflected by a drop in the
intercysteine distance from 38 A˚ to 8 A˚. Two major structural
features of Uba1 and Ubc1 and other E2s contribute to this dif-
ferent behavior. For Uba1, in which the UFD is connected to
the adenylation domain by the extended UFD linker, a small
change at the hinge translates into a large shift in the orientation
of the whole UFD. For Ubc1, where its core domain has a rectan-
gular structure which is anticipated for the core domains of all
E2s, a small rotation at the base translates into a large translation
of the catalytic cysteine.
Three aspects of the Uba1 structure are consistent with the
possibility that the UFD could rotate relative to the remainder
of the E1. First, the two Uba1 molecules present in the asymmet-
ric unit display the aforementioned conformational change of the
UFD, which anticipates the movement required to allow trans-
thioesterification (Figure 4B). Second, the three central residues
in the linker, Ile912, Ala913, and Ser914, do not engage in spe-
cific side chain contacts, either to the remainder of the E1 struc-274 Cell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc.ture or to the bound Ub. Third, the UFD buries a relatively small
interface with the AAD (400 A˚2 of total surface area), suggesting
that the UFD may act as an independent unit rather than as part
of a tighter complex. Similar domain rotations can be found in en-
zymes participating in Ubl transfer that involve the HECT class
E3 ligases (Verdecia et al., 2003). The existence of a different
set of conformational changes involved in the recruitment of cog-
nate E2s to the E1 of Ub on one hand and NEDD8/SUMO on the
other hand could potentially reflect the fact that in the latter path-
ways only a single E2 enzyme exists, which apparently needs to
unlock the respective E1 enzyme.
E1 Activity Depends on a Flexible Hinge
in the UFD Linker
To test the importance of the relative flexibility of this region on
the Ub transfer from E1 to E2, we constructed mutant forms of
Uba1, which contain the intact UFD necessary for proper E2
binding but are restricted in the conformational flexibility of their
hinge regions. On the basis of the fact that a mutation to proline
restricts the rotation about the polypeptide backbone (Rama-
chandran and Sasisekharan, 1968) and two previous studies
characterizing comparable domain rotations for the WWP1
HECT E3 ligase (Verdecia et al., 2003) and the NEDD8-E1 (Huang
et al., 2005), we singly mutated the central residues of the UFD
hinge, Ile912 (data not shown), Ala913, and Ser914, to proline
(Figure 5C) and also constructed double proline mutants.
Whereas the single Pro substitutions and the A913P/S914P
double mutant only showed modest reductions in activity in
the single-turnover pulse-chase Uba1-Ubc1 transthioesterifica-
tion assay, there was a drastic drop in activity for the I912P/
S914P variant (Figure 5E). Because of the presence of prolines
at positions 911 and 915, the I912P/S914P mutant generates
the sequence of Pro-Pro-Ala-Pro-Pro in the linker that
Figure 5. Model of the Uba1 Transthioester-
ification Complex and its Biochemical Vali-
dation
(A) Pretransthioesterification step. The following
applies to (A) and (B). IAD, AAD, 4HB, FCCH and
SCCH are displayed in surface representation.
UFD, Ub(A), which corresponds to Ub bound non-
covalently at the adenylation active site as ob-
served in our crystal structure, and Ubc1 (modeled
as described in the Experimental Procedures) are
shown in ribbon representation. All domains are
color coded as in Figure 1, with Ubc1 in gray.
The catalytic cysteines in Uba1 and Ubc1
(Cys600 and Cys88, respectively) are highlighted
in pink, and the distance between them (38 A˚)
is indicated next to the dashed line.
(B) A rotation around the UFD linker hinge would
allow the two catalytic cysteines to come into
close proximity, as indicated by the dotted line
and corresponding distance (8 A˚), to facilitate
the transthioesterification reaction. Color coded
as in (A), with Ub(T), in which Ub is thioester-linked
to Cys88 of Ubc1, as an orange ribbon (modeled
as described in the Experimental Procedures on
the basis of the Ubc1Ub thioester intermediate;
PDB entry 1FXT [Hamilton et al., 2001]) and the
UFD in tan. N and C termini of Ubc1 are labeled.
Residues 779–785 from SCCH were removed to
allow for a clearer presentation of Cys600 of
Uba1 and the C-terminal tail of Ub(T).
(C) Close-up view and superposition of the two
UFD linker conformations displayed in (A) and (B)
with the same color code (pretransthioesterifica-
tion in red, transthioesterification in tan). The
model presented in (B) predicts that the UFD
needs to rotate approximately 40, as indicated
by the arrow, to assume a position that is compe-
tent for transthioesterification.
(D) Close-up view of the conformation shown in (B)
highlighting the contribution of the SCCH loop
(residues 775–795) to Ubc1 binding. The loop is
enclosed by a black oval, and Ala124 of Ubc1 is
highlighted as a red sphere.
(E) Transthioesterification activity of the UFD
linker, DSCCH loop, and Ubc1 A124K mutants.
The experiments were carried out as described
in Figure 3C. Wild-type and mutants of Uba1 and
Ubc1 are denoted on the top. The amount of
Uba1 and Ubc1 used in these experiments is
shown.apparently reduces its conformational flexibility to such an ex-
tent that Ubc1 bound to UFD can no longer efficiently approach
the active site cysteine in the SCCH domain to initiate trans-
thioesterification.
E1 Recognizes Cognate E2 Enzymes via Multiple
Binding Sites
The SCCHs of the E1s for Ub, NEDD8, and SUMO vary widely in
their lengths and sequences. However, both Ub- and SUMO-E1
contain a large surface loop near the catalytic cysteine in a similar
position. A recent study suggests that Ubc9 directly binds to this
loop region in the SCCH of Sae2, thus indicating that the intrinsic
affinity between the E2 and the SCCH of E1 further guides thetranslocation of E2 toward the catalytic cysteine of E1 (Wang
et al., 2007). Since the E1-catalyzed step is critical in defining
Ubl specificity and fidelity for the respective downstream cas-
cade by ensuring that its cognate E2 is charged with the correct
Ubl, it is an appealing idea that additional E2 specificity is
achieved within the E1-E2 transthioesterification complex by
the interface between E2 and the SCCH. Consequently, two
interaction interfaces between E1 and E2 would collaborate dur-
ing the E1-E2 transthioesterification cycle. In line with this as-
sumption, our Ub-E1 transthioesterification model also reveals
a potential interface between the SCCH and E2. It appears that
the central loop region (residues 775–795) of the SCCH would
be in close contact with the incoming E2 and that theCell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc. 275
transthioesterification reaction may require it to move away from
E2 to avoid a steric clash (Figure 5D). Indeed, the C-terminal part
of the loop in the SCCH (residues 786–793) is disordered in the
crystal structure, indicating that this loop is characterized by
high conformational flexibility. These observations raised the
possibility that the SCCH of the Ub-E1 may have an intrinsic af-
finity for its E2s, and we have tested this hypothesis for the Uba1-
Ubc1 complex.
In agreement with this idea, we observe that the mutant in which
residues 776 to 793 of the SCCH are deleted displays a significant
reduction in activity in the single-turnover pulse-chase Uba1-
Ubc1 transthioesterification assay (Figure 5E and Figure S3B).
At the same time, we also generated the A124K mutant of Ubc1
because this residue is in close proximity to the SCCH loop in
our model, and Lys147, the corresponding residue in Ubc12
(the E2 for NEDD8), is in close proximity to the SCCH domain
(Huang et al., 2007). The corresponding K147A variant was found
to significantly enhance mischarging of Ubc12 with Ub (Huang
et al., 2008). Consistent with these observations, we detect that
the A124K mutant of Ubc1 shows significantly reduced activity
in the transthioesterification assay (Figure 5E and Figure S3B).
Taken together, our biochemical data confirm that a secondary
interface between the E2 enzymes and the SCCH domain exists
because mutations in either protein in the regions predicted to
interact with each other impair transthioesterification.
Conclusions
Uba1 consists of a distinct arrangement of modular domains
connected by long, flexible linkers, which together create a large
central groove. This architecture appears to be ‘‘primed’’ for sig-
nificant conformational changes. Indeed, a comparison of the
two copies of Uba1 in the asymmetric unit indicates an 10 ro-
tation of UFD. In addition, structural comparisons between dif-
ferent E1s and E1/Ubl complexes revealed that the domains
are flexibly tethered to each other, with relative rotations of
10 to 20 about the hinge loops between domains (Huang
et al., 2004a; Lois and Lima, 2005; Walden et al., 2003a, 2003b).
In addition to features shared among the E1s from different
pathways, the structural analysis of Uba1 revealed a recognition
mechanism of the E1 for Ub and its E2s. Interactions with Ub are
extensive and involve three different faces of Ub. Within this
framework, Uba1 provides key residues contacting the Arg72
of Ub, which has been described as being crucial for Ub discrim-
ination. Uba1 also features a much wider canyon between its
SCCH and UFD than other E1s, which might allow it to accom-
modate a variety of its E2 partners, some with varying N- and
C-terminal extensions outside the E2 core domain, and the
UFD appears poised in the unobstructed conformation ready
to accept available E2s.
The key questions on the mechanism of Uba1 function include
the nature and timing of the Uba1 conformational changes dur-
ing the steps of thioester formation with the C terminus of Ub
and the transthioesterification reaction, as well as the details of
protein-protein interactions between E1 and E2 during the latter.
The model presented here, which is supported by our biochem-
ical data, predicts that Uba1 will undergo a distinct UFD move-
ment during the E1-E2 handoff. Also, the UFD and SCCH of
Uba1 display an intrinsic affinity for its E2s, thus contributing to276 Cell 134, 268–278, July 25, 2008 ª2008 Elsevier Inc.selectivity in E2 recruitment. However, this model will have to
be further refined in future studies.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
N-terminal hexahistidine (His6)-tagged Saccharomyces cerevisiae Uba1 (resi-
dues 10–1024) was cloned into pET28a (Novagen) and expressed in Escheri-
chia coli. Intein-tagged S. cerevisiae Ubc1 and Ub were cloned into pTXB1
(New England Biolabs) and expressed in E. coli. Uba1 was purified by Ni-NTA
chromatography followed by thrombin cleavage of the His tag, hydrophobic
interaction, and size-exclusion chromatography. Ubc1 and Ub were affinity-
purified with the IMPACT (NEB) system, followed by size-exclusion chroma-
tography. Prior to crystallization, Uba1 was concentrated to 5 mg/ml by ultra-
filtration in 25 mM Tris-HCl (pH 7.6), 200 mM NaCl and 5 mM dithiothreitol
(DTT).
Crystallization and Structure Determination
Crystals of the Uba1-Ub complex were grown by incubation of Uba1 and Ub
together at concentrations of 5 mg/ml each in a molar ratio of 1.0:1.3 at 4C for
1 hr, followed by hanging drop vapor diffusion at room temperature against
a reservoir containing 0.5 M L-proline and 17%–20% PEG 5000 MME. Crys-
tals were transferred into mother liquor supplemented with 20% PEG 400 and
5% sucrose and were flash frozen in liquid nitrogen. Diffraction data were col-
lected at beamline X29 of the NSLS. The HKL2000 package (Otwinowski and
Minor, 1997) was used to index, integrate, and scale the diffraction data. The
structure was solved by domain-wise molecular replacement with several
search models. Details of crystallization and structure determination are de-
scribed in the Supplemental Experimental Procedures. A summary of the
data collection and structure refinement statistics is presented in Table 1. A
representative portion of a SIGMAA weighted 2Fo-Fc electron density map
is shown (Figure S1). The model possesses an excellent overall stereochem-
istry, with 95.0% of all residues in favored regions and 4.2% in the additionally
allowed regions of the Ramachandran diagram on the basis of an analysis with
MolProbity (Davis et al., 2004). All figures were made with PyMOL (DeLano
Scientific).
Generation of Transthioesterification Models for Uba1
For the pretransthioesterification model, the Ubc1core domain (residues 1–150,
PDB entry 1TTE [Merkley and Shaw, 2004]) were modeled onto the Uba1-Ub
complex structure in O (Jones et al., 1991), first by least-squares superposition
of the UBA3 UFD-Ubc12core complex (PDB entry 1Y8X [Huang et al., 2005])
with the UFD of Uba1 and then by least-squares superposition of the Ubc1core
with the Ubc12core. The structure of the UBA3 UFD and Ubc12core was subse-
quently removed.
For the transthioesterification model, the Ubc1Ub intermediate was mod-
eled onto the Uba1-Ub complex structure in O, first by superposition of the
UBA3 UFD-Ubc12core complex with the UFD of Uba1 and then by superposi-
tion of the Ubc1Ub thioester complex (PDB entry 1FXT [Hamilton et al.,
2001]) with the Ubc12core. The structures of the UBA3 UFD and Ubc12core
were subsequently removed.
Single-Turnover Pulse-Chase Ub E1-E2 Transthioesterification
Assay
Uba1 (1.0 mM) was incubated with Ub (4.1 mM) in 25 mM Tris-HCl (pH 7.5),
50 mM NaCl, 2.5 mM ATP, and 5 mM MgCl2 for 30 min at room temperature
in ‘‘pulse’’ reactions. Ub was labeled with fluorescent dye with the IRDye pro-
tein labeling kit (LI-COR Biosciences). The pulse reaction was terminated by
the addition of 200 mM EDTA for 15 min at room temperature (added as 1/7
the volume of the pulse reaction). This reaction was diluted into an equal volume
of ‘‘chase’’ mixes containing a final concentration of 25 mM Tris-HCl (pH 7.5)
and 50 mM NaCl, in the presence of Ubc1 (3.0 mM final concentration). Sam-
ples were taken at different time points after the start of the chase reaction
and stopped by the addition of 53 SDS-Laemmli buffer without DTT and re-
solved via SDS-PAGE. The decay of the Uba1Ub complex and the formation
of the Ubc1Ub complex were simultaneously analyzed on the same gel for
the wild-type and two or three mutants. The gel was briefly rinsed with water
before the infrared fluorescent image of the gel was taken with an Odyssey
infrared imaging system (LI-COR Biosciences). The Odyssey software was
used for quantification.
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Coordinates and structure factor amplitudes have been deposited in the
Protein Data Bank under accession number 3CMM.
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